36 Followers on Owler
OverviewCompetitorsFundingNews & Insights

SCYNEXIS Competitors or Alternatives

SCYNEXIS's top competitors include Amplyx, Entasis and Cidara.

Unlock 11 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

SCYNEXIS's company profile

Marco Taglietti

President & CEO

88/100
60
$238.4M
$3.7M
  • $238.4M
    $3.7M
  • 60
    $238.4M
  • $3.7M
  • 88/100
  • 60
  • $238.4M
  • $3.7M
View ProfileView
1
SCYNEXIS's Competitor - Amplyx logo

Ciara Kennedy

President & CEO

89/100
25 - 100
$170.7M
$5M - 25M
  • $170.7M
    $5M - 25M
  • 25 - 100
    $170.7M
  • $5M - 25M
  • 89/100
  • 25 - 100
  • $170.7M
  • $5M - 25M
View ProfileView
2
SCYNEXIS's Competitor - Entasis logo

Manos Perros

President & CEO

88/100
50
$287M
$7M
  • $287M
    $7M
  • 50
    $287M
  • $7M
  • 88/100
  • 50
  • $287M
  • $7M
View ProfileView
3
SCYNEXIS's Competitor - Cidara logo

Jeffrey Stein

President & CEO

89/100
90
$510.8M
$1.3M
  • $510.8M
    $1.3M
  • 90
    $510.8M
  • $1.3M
  • 89/100
  • 90
  • $510.8M
  • $1.3M
View ProfileView
4
SCYNEXIS's Competitor - Pfizer logo

Albert Bourla

Chairman & CEO

69/100
83,000
$1B
$63.6B
  • $1B
    $63.6B
  • 83,000
    $1B
  • $63.6B
  • 69/100
  • 83,000
  • $1B
  • $63.6B
View ProfileView
5
SCYNEXIS's Competitor - Merck logo

Robert M. Davis

Chairman & CEO

78/100
69,000
$8B
$64.2B
  • $8B
    $64.2B
  • 69,000
    $8B
  • $64.2B
  • 78/100
  • 69,000
  • $8B
  • $64.2B
View ProfileView
SCYNEXIS's top 14 competitors are Amplyx, Entasis, Cidara, Gilead, Pfizer, Merck, Astellas, Viamet Pharma, NGM Bio, Hyperion Therapeutics, Auspex Pharmaceuticals, Iconic Therapeutics, Gossamer Bio and Novacta. Together they have raised over 19.5B between their estimated 184.8K employees. SCYNEXIS has 60 employees and is ranked 10th among it's top 10 competitors. The top 10 competitors average 12,323.

SCYNEXIS VS Amplyx

Amplyx is SCYNEXIS's top competitor. Amplyx is headquartered in San Diego, California, and was founded in 2006. Like SCYNEXIS, Amplyx also operates in the Biotechnology field. Amplyx generates 266% the revenue of SCYNEXIS.

SCYNEXIS VS Entasis

Entasis is seen as one of SCYNEXIS's top competitors. Entasis's headquarters is in Waltham, Massachusetts, and was founded in 2015. Like SCYNEXIS, Entasis also works within the Biotechnology industry. Entasis generates 186% of SCYNEXIS's revenue.

SCYNEXIS VS Cidara

Cidara has been one of SCYNEXIS's top competitors. Cidara was founded in 2012, and its headquarters is in San Diego, California. Like SCYNEXIS, Cidara also works within the Biotechnology field. Cidara has 30 more employees than SCYNEXIS.

Looking for similar companies to SCYNEXIS?

Similar Companies

Pharmaceuticals & Biotechnology companies in Jersey City

See 18 companies 
Biotechnology companies in New Jersey

See 414 companies 
Companies in Jersey City with revenue in $100K-5.0M range

See 533 companies 
Biotechnology companies in New York Metropolitan Area

See 859 companies 
Pharmaceuticals & Biotechnology companies in New Jersey

See 1,085 companies 
Companies in Jersey City with employees in 25-100 range

See 1,151 companies 
Pharmaceuticals & Biotechnology companies in New York Metropolitan Area

See 1,762 companies 
Biotechnology companies with revenue in $100K-5.0M range

See 4,539 companies 
Biotechnology companies with employees in 25-100 range

See 5,169 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for SCYNEXIS and SCYNEXIS's Competitors

April 22, 2025BioSpace
Combining Trodelvy with Keytruda and pushing it into the frontline setting could "potentially double" the ADC's market in metastatic triple-negative br...
April 23, 2025Yahoo
In This Article: Merck (MRK) Reports Q1: Everything You Need To Know Ahead Of Earnings Global pharmaceutical company Merck (NYSE:MRK) will be reporting...
April 21, 2025Benzinga
Pfizer Inc (NYSE:PFE) is scheduled to release its first quarter 2025 earnings on 29 April. Latest Ratings for PFE DateFirmActionFromTo Feb 2022Morgan S...
April 23, 2025Yahoo
In This Article: Seres Therapeutics, Inc. CAMBRIDGE, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live ...
April 22, 2025Biospectrum Asia
Gilead Sciences to propel healthcare innovation and cell therapy advancement in Abu Dhabi...
April 22, 2025Seeking Alpha
April 23, 2025PMLiVE
More than 11,800 people were living with the genetic blood disorders in the UK in 2023/2024...
April 22, 2025Clinical Trials Arena
Gilead Sciences has reported positive topline data from the Phase III ASCENT-04/KEYNOTE-D19 trial of Trodelvy and MSD's Keytruda combo. The post Gilead...
April 22, 2025Pharmacy Business
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi (marstacimab) to prevent or reduce bleeding in patients aged 12 ye...
April 22, 2025BioSpace
Alnylam and BridgeBio are competing for people who are switching from Pfizer's blockbuster ATTR amyloidosis drug tafamidis while all three companies ar...

Frequently Asked Questions about SCYNEXIS

  1. Who are SCYNEXIS's top competitors?

    SCYNEXIS's top 3 competitors are Amplyx, Entasis, Cidara.

  2. Who is similar to SCYNEXIS?

    Amplyx is the most similar to SCYNEXIS. Entasis and Cidara are also similar to SCYNEXIS.

  1. Are SCYNEXIS and Amplyx competitors?

    Yes, Amplyx is one of SCYNEXIS’s top competitors.